Participants in a clinical trial lived longer years longer after increased immune response to glioblastoma slowed progression ...

A Phase 1 trial shows a personalized DNA vaccine (GNOS-PV01) is safe and doubles survival rates for aggressive glioblastoma.

A potential breakthrough in the fight against glioblastoma, the deadliest form of brain cancer, is emerging from UVA Cancer Center. University of Virginia scientists, with support from the National ...

Survival rate surpasses historical outcomes in a small phase I study ...

Researchers at the UNC School of Medicine and the UNC Eshelman School of Pharmacy have made a breakthrough that could modernize treatment for glioblastoma, a fast-growing and deadly form of brain ...

Michael Bolton’s battle with glioblastoma has brought renewed attention to one of the most complex, deadly and treatment-resistant cancers. The singer, 72, told People he was diagnosed in December ...

Medical Oncologists’ Beliefs, Practices, and Knowledge Regarding Marijuana Used Therapeutically: A Nationally Representative Survey Study Data abstracted from registry databases included patients from ...

Glioblastoma patients, long shut out from immunotherapies that have transformed patient care in other cancers, could finally benefit from a new treatment option. Boston cancer researchers have found ...

A personalized vaccine to treat glioblastoma, a fast-growing and incurable brain cancer that affects four in 100,000 people ...